These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20350941)

  • 21. Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes.
    Landman D; Salamera J; Quale J
    J Clin Microbiol; 2013 Dec; 51(12):4106-11. PubMed ID: 24088860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY; Ng LS; Chen DM
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
    DiPersio JR; Dowzicky MJ
    Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases.
    Ku YH; Lee MF; Chuang YC; Chen CC; Yu WL
    J Microbiol Immunol Infect; 2015 Dec; 48(6):699-702. PubMed ID: 24388585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy of polymyxin B, tigecycline and meropenem against carbapenem-resistant Enterobacter cloacae complex isolates.
    Alves PH; Boff RT; Barth AL; Martins AF
    Diagn Microbiol Infect Dis; 2019 May; 94(1):81-85. PubMed ID: 30638946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the mechanisms of colistin resistance in Klebsiella aerogenes of clinical origin.
    Liao W; Quan J; Liu L; Zhao D; Jiang Y; Du X; Zhao F; Yu Y; Zhou Z
    Int J Antimicrob Agents; 2020 Jun; 55(6):105990. PubMed ID: 32330580
    [No Abstract]   [Full Text] [Related]  

  • 30. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
    Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
    Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.
    Fernández-Mazarrasa C; Mazarrasa O; Calvo J; del Arco A; Martínez-Martínez L
    J Clin Microbiol; 2009 Mar; 47(3):827-9. PubMed ID: 19144806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp.
    Woodford N; Hill RL; Livermore DM
    J Antimicrob Chemother; 2007 Mar; 59(3):582-3. PubMed ID: 17229831
    [No Abstract]   [Full Text] [Related]  

  • 33. In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
    Cai Y; Lim TP; Teo J; Sasikala S; Lee W; Hong Y; Chan EC; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5238-46. PubMed ID: 27324776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia.
    Gordon NC; Wareham DW
    J Clin Microbiol; 2009 Sep; 47(9):3024-5. PubMed ID: 19641071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump.
    Telke AA; Olaitan AO; Morand S; Rolain JM
    J Antimicrob Chemother; 2017 Oct; 72(10):2715-2721. PubMed ID: 29091215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae.
    Keeney D; Ruzin A; Bradford PA
    Microb Drug Resist; 2007; 13(1):1-6. PubMed ID: 17536927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient.
    Jorgensen SCJ; McDonald P; Mynatt RP; Pogue JM; Lerner SA; Dhar S; Salimnia H; Rybak MJ
    J Antimicrob Chemother; 2018 Dec; 73(12):3529-3531. PubMed ID: 30188993
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).
    Treviño M; Moldes L; Martínez-Lamas L; Varón C; Regueiro BJ
    Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1253-8. PubMed ID: 19504135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.
    Aoki K; Harada S; Yahara K; Ishii Y; Motooka D; Nakamura S; Akeda Y; Iida T; Tomono K; Iwata S; Moriya K; Tateda K
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.